WithdrawnNot Applicable

Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor

United States0Started 2011-11-01

Plain-language summary

This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Samples of RTK and ATRT provided by the Children?s Oncology Group (COG)

What they're measuring

Molecular differences between RTK and the ATRT

Timeframe: Up to 3 months

Trial details

NCT IDNCT01453465

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2011-12-01

View on ClinicalTrials.gov More Childhood Atypical Teratoid/Rhabdoid Tumor trials